The U.S. Food and Drug Administration (FDA) is warning consumers not to use two unapproved drug products that are being marketed as dietary supplements for weight loss. Emagrece Sim Dietary Supplement, also known as the Brazilian Diet Pill and Herbathin Dietary Supplement may contain several active ingredients, including controlled substances, found in prescription drugs that could lead to serious side effects or injury.
At the request of the U.S. Food and Drug Administration (FDA), the U.S. Attorney’s Office for the Western District of Pennsylvania filed a Complaint for Forfeiture against Lipodrene, a dietary supplement that contains ephedrine alkaloids. The U.S. Marshals, seized the dietary supplement Lipodrene located at ATF Fitness Products, Inc., in Oakmont, PA.
Genelabs Technologies Inc. said the U.S. Food and Drug Administration has asked for additional Phase III clinical trial of its experimental lupus drug Prestara.
Each year more than 1 million cases of skin cancer are reported. The most common type of skin cancer is basal cell cancer, which accounts for 80 percent of all skin cancers. The other types of skin cancer includes squamous and melanoma.
Older adults who regularly eat whole grains like high-fiber cereals and cooked oatmeal may be less likely to develop a cluster of conditions that raise the risk of heart attack and stroke, a new study suggests.
Though we all love satiating our taste buds by eating all the goodies available, especially so in this festive season, we should be, at the same time, careful enough to choose what is right.
The Food and Drug Administration (FDA) has approved the drug Revlimid (lenalidomide) for the treatment of patients with a subtype of Myelodysplastic Syndrome (MDS). The subtype is MDS patients with deletion 5q cytogenetic abnormality.
The Food and Drug Administration (FDA) announced the tentative approval of Stavudine (stav’ yoo deen) for Oral Solution, 1 mg/mL to be manufactured by Aurobindo Pharma LTD. of Hyderabad, India. This product is the first generic version of the already approved Zerit for oral solution manufactured by Bristol-Myers Squibb. This child-friendly product is indicated for use in pediatric patients with HIV, from birth through adolescence. This product will now be available for consideration for purchase under the President’s Emergency Plan for AIDS Relief (PEPFAR).
The U.S. Food & Drug Administration (FDA) approved the use of Tamiflu (oseltamivir phosphate) for prevention (prophylaxis) of seasonal influenza (“flu”) in children 1 to 12 years of age who had close contact with an infected individual. This is the first drug approved for prevention of both influenza A and B in pediatric patients.
As part of its continuing initiative to provide Americans with the information they need to make healthy nutritional choices about foods and dietary supplements, the Food and Drug Administration (FDA) today announced that whole grain barley and barley-containing products are allowed to claim that they reduce the risk of coronary heart disease (CHD).